A hypothesis relating lymphocyte phosphorylation and transport of ara-C (cytarabine) to its antiviral activity.
D000818:Animals; D000998:Antiviral Agents / Q000378:metabolism*; D001693:Biological Transport, Active; D002459:Cell Fusion; D002478:Cells, Cultured; D002540:Cerebral Cortex; D002633:Chemotaxis; D002644:Chickenpox / Q000188:drug therapy; D003561:Cytarabine / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D004279:DNA, Viral / Q000096:biosynthesis; D004285:Dogs; D000882:Haplorhini; D006564:Herpesviridae / Q000378:metabolism; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007111:Immunity, Cellular; D007267:Injections; D007668:Kidney; D008214:Lymphocytes / Q000378:metabolism*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008657:Metabolic Clearance Rate; D051379:Mice; D010085:Oxidative Phosphorylation; D010770:Phosphotransferases / Q000037:antagonists & inhibitors; D011817:Rabbits; D051381:Rats
D000998:Antiviral Agents; D004279:DNA, Viral; D003561:Cytarabine; D010770:Phosphotransferases